These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2444712)

  • 1. Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning.
    Althof SE; Turner LA; Levine SB; Risen C; Kursh ED; Bodner D; Resnick M
    J Sex Marital Ther; 1987; 13(3):155-67. PubMed ID: 2444712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: a long-term prospective study.
    Althof SE; Turner LA; Levine SB; Risen CB; Bodner D; Kursh ED; Resnick MI
    J Sex Marital Ther; 1991; 17(2):101-12. PubMed ID: 1920466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence.
    Turner LA; Althof SE; Levine SB; Risen CB; Bodner DR; Kursh ED; Resnick MI
    J Sex Marital Ther; 1989; 15(3):163-76. PubMed ID: 2593154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction].
    Gall H; Sparwasser C; Bähren W; Scherb W; Holzki G; Irion R
    Urologe A; 1992 Jan; 31(1):31-6. PubMed ID: 1553802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intracavernosal injection of papaverine hydrochloride on orgasm latency.
    Levitt EE; Mulcahy JJ
    J Sex Marital Ther; 1995; 21(1):39-41. PubMed ID: 7608997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 years' experiences with cavernosal autoinjection therapy].
    Stief CG; Thon WF; Scherb W; Gall H; Bähren W
    Urologe A; 1987 Sep; 26(5):294-6. PubMed ID: 2446413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracavernosal injection therapy for impotence: preliminary results.
    Gilling PJ; Wright WL; Gray JM
    N Z Med J; 1988 Jun; 101(848):423-4. PubMed ID: 3393333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.